The whole rationale for going up the credit scale is not based on the NIM.
In effect it"s the NIM less bad debts that's the measure.
So SVR can make a lower NIM but still a higher EBITDA due to lower bad debts.
Of course it'll take a while to filter through as the old lower credit customers are much more likely to be defaulting in the current environment.
- Forums
- ASX - By Stock
- SVR
- 52w high
SVR
solvar limited
Add to My Watchlist
0.61%
!
$1.66

52w high, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $324.1M |
Open | High | Low | Value | Volume |
$1.67 | $1.67 | $1.64 | $8.322K | 5.016K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 4420 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 12530 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 4420 | 1.655 |
3 | 3772 | 1.650 |
3 | 2913 | 1.645 |
3 | 3371 | 1.640 |
3 | 3432 | 1.635 |
Price($) | Vol. | No. |
---|---|---|
1.670 | 12530 | 4 |
1.675 | 1401 | 2 |
1.680 | 500 | 1 |
1.685 | 8985 | 4 |
1.690 | 116365 | 3 |
Last trade - 10.13am 26/06/2025 (20 minute delay) ? |
Featured News
SVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online